Lataa...
Membrane fusion FerA domains enhance adeno-associated virus vector transduction
The recombinant adeno-associated virus (rAAV) vector has been successfully employed in clinical trials for patients with blindness and bleeding diseases as well as neuromuscular disorders. To date, it remains a major challenge to achieve higher transduction efficiency with a lower dose of rAAV vecto...
Tallennettuna:
| Julkaisussa: | Biomaterials |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7080211/ https://ncbi.nlm.nih.gov/pubmed/32114218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2020.119906 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|